Filing Details

Accession Number:
0001209191-13-040859
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-15 15:07:20
Reporting Period:
2013-08-14
Filing Date:
2013-08-15
Accepted Time:
2013-08-15 15:07:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
805928 Axogen Inc. AXGN Electromedical & Electrotherapeutic Apparatus (3845) 411301878
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1492710 Gene Gregory Freitag C/O Axogen, Inc.
13859 Progress Boulevard, Suite 100
Alachua FL 32615
Cfo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-14 8,334 $3.00 32,652 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reporting person purchased these shares in its individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On August 9, the trade date for the public offering and the first day AxoGen shares were traded on the NASDAQ Capital Market, the closing sale price reported by NASDAQ was $2.98 per share. The public offering closed on August 14, 2013, and the closing sale price reported by NASDAQ on August 14, 2013 was $2.97 per share.